Article info

PDF
Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer

Authors

  1. Correspondence to Dr Carla Masini, Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Forlì 47014, Italy; carla.masini{at}irst.emr.it
View Full Text

Citation

Sanogo S, Silimbani P, Gaggeri R, et al
Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer

Publication history

  • Received February 23, 2018
  • Revised April 25, 2018
  • Accepted May 1, 2018
  • First published May 15, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.